Skip to main content

Diabetes with LDL-C greater than 100 – Use of a Lipid Lowering Agent

CBE ID
0618
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

The percentage of patients with a diagnosis of diabetes mellitus aged 41 to 75 years, or aged 18 to 40 years with additional risk factors, whose most recent LDL-C value is more than 100 mg/dL and who are taking a lipid lowering agent.

    Measure Specs
      General Information
      1.14 Numerator

      Patients who are taking a lipid lowering agent

      1.15 Denominator

      Patients with a diagnosis of diabetes mellitus aged 41 to 75 years, or aged 18 to 40 years with additional risk factors, whose most recent LDL-C value is more than 100 mg/dL.

      Exclusions

      SPECIFIC DENOMINATOR EXCLUSIONS

      One of the following is correct:
      1. Presence of patient data c via online PHR or telephonic nurse assessment confirming breast feeding in the past 6 months
      2. If Pregnancy Loose Version Validation is confirmed for the member (see below)

      General exclusions:
      1. Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
      2. Patients who have been in a skilled nursing facility in the last 3 months
      3. Patients who are terminally ill or in Hospice
      4. Patient or provider feedback indicating allergy, intolerance or other contraindication to lipid lowering therapy anytime in the past

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      ActiveHealth Management
      Steward POC email
      mvemireddy@activehealth.net
                Public Comments